Improving quality and diffusing best practices: the case of schizophrenia.
The slow spread of treatments supported by empirical evidence and the rapid diffusion of treatments lacking such support play major roles in the lower quality of mental health care received by people with severe mental illnesses compared with the care of less severely ill people. Further, the rapid spread of treatments that are of low cost-effectiveness limits the system's ability to provide the full gamut of high-value treatments available to treat this vulnerable population. Using the case of schizophrenia, we review the context in which these paradoxical patterns of diffusion have occurred, and we propose policy solutions.
Horvitz-Lennon
Marcela
M
Western Psychiatric Institute and Clinic, University of Pittsburgh (Pennsylvania) Medical School, USA. horvitzlennonmv@upmc.edu
Donohue
Julie M
JM
Domino
Marisa E
ME
Normand
Sharon-Lise T
SL
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D015897:Comorbidity; D003362:Cost-Benefit Analysis / Q000639:trends; D003430:Cross-Sectional Studies; D004059:Diffusion of Innovation; D016527:Drug Costs / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine / Q000191:economics / Q000639:trends*; D005380:Financing, Government / Q000191:economics; D005544:Forecasting; D006291:Health Policy / Q000191:economics / Q000639:trends*; D006301:Health Services Needs and Demand / Q000191:economics / Q000639:trends; D006801:Humans; D008484:Medicaid / Q000191:economics; D006278:Medicare / Q000191:economics; D011785:Quality Assurance, Health Care / Q000191:economics / Q000639:trends*; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D014481:United States
D014150:Antipsychotic Agents